173 related articles for article (PubMed ID: 16740157)
1. Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.
Yamashita H; Kitayama J; Kanno N; Yatomi Y; Nagawa H
BMC Cancer; 2006 Jun; 6():147. PubMed ID: 16740157
[TBL] [Abstract][Full Text] [Related]
2. Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer.
Yamashita H; Kitayama J; Nagawa H
Jpn J Clin Oncol; 2005 Oct; 35(10):595-600. PubMed ID: 16186176
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.
Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Ito M; Washizawa N; Kaneko H
Surg Today; 2016 Dec; 46(12):1394-1401. PubMed ID: 27160890
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer.
Wakatsuki K; Matsumoto S; Migita K; Ito M; Kunishige T; Nakade H; Nakatani M; Kitano M; Sho M
World J Surg; 2017 Aug; 41(8):2068-2077. PubMed ID: 28321554
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
Lee JH; Ryu KW; Kim S; Bae JM
Hepatogastroenterology; 2004; 51(60):1860-3. PubMed ID: 15532844
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor.
Ashizawa T; Okada R; Suzuki Y; Takagi M; Yamazaki T; Sumi T; Aoki T; Ohnuma S; Aoki T
Gastric Cancer; 2005; 8(2):124-31. PubMed ID: 15864720
[TBL] [Abstract][Full Text] [Related]
7. Correlation between coagulation function, tumor stage and metastasis in patients with renal cell carcinoma: a retrospective study.
Xiao B; Ma LL; Zhang SD; Xiao CL; Lu J; Hong K; Liao HY
Chin Med J (Engl); 2011 Apr; 124(8):1205-8. PubMed ID: 21542997
[TBL] [Abstract][Full Text] [Related]
8. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
9. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
10. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
[TBL] [Abstract][Full Text] [Related]
11. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
12. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer.
Lu K; Zhu Y; Sheng L; Liu L; Shen L; Wei Q
Hepatogastroenterology; 2011; 58(110-111):1507-10. PubMed ID: 21940318
[TBL] [Abstract][Full Text] [Related]
13. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
17. Significance of palliative gastrectomy for late-stage gastric cancer patients.
Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients.
Maehara Y; Tomisaki S; Oda S; Sakaguchi Y; Ichiyoshi Y; Sugimachi K
Anticancer Res; 1994; 14(6B):2755-7. PubMed ID: 7872713
[TBL] [Abstract][Full Text] [Related]
20. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
